Beautifully engraved certificate from the G.D. Searle & Company
in 1976. This historic document was printed by the American Banknote Company and has an
ornate border around it with a vignette of an allegorical woman sitting infront of a globe. This item has the printed signatures of the Company’s President, (D. C. Searle) and Secretary and is
over 25 years old.
Pharmacia Corporation is a first-tier global pharmaceutical company with an industry-leading growth rate, a robust product portfolio, a high-potential research and development pipeline, and a dynamic agricultural subsidiary in Monsanto Company.
Pharmacia Corporation was created in April 2000 through the merger of Pharmacia & Upjohn with Monsanto Company and its G.D. Searle unit. Pharmacia employs 59,000 people worldwide and has research, manufacturing and administrative sales operations in more than 60 countries.
Pharmacia is implementing a new, comprehensive system for managing environmental, safety and health (ESH) issues and has adopted a series of ESH standards to guide operations worldwide. These are described in a detailed Environment, Safety and Health Report that includes the corporate ESH policy, discussions of the company's approach to some significant issues, stories about successful ESH initiatives at the local level and a detailed accounting of Pharmacia waste generation and waste management worldwide.
Pharmacia is one of the fastest-growing competitors in the global pharmaceutical industry. In our core prescription pharmaceuticals business, we are recognized as an innovative leader in a number of therapeutic areas, including arthritis/inflammation, pain management, antibiotics, oncology and ophthalmology.
They also have a strong position in a number of related businesses, including consumer healthcare, animal health, pharmaceutical commercial services (fine chemicals and global contract manufacturing) and diagnostics (US and worldwide).
Their focus on Customer relationships extends to our 85 percent owned agricultural subsidiary, Monsanto Company. Monsanto's unique combination of agricultural products and unparalleled resources in plant biotechnology offers to customers innovative solutions to improve farm productivity and to reduce the costs and risks of farming.
2001 Pharmacia completes spin-off of research activities into Swedish-based Biovitrum AB
2001 Pharmacia announced collaboration with Celltech Group plc to develop CDP-870
2000 Initial Public Offering (IPO) of the Monsanto agricultural business is completed
2000 ZYVOX is launched
April 3, 2000 Pharmacia Corporation is established and based in Peapack, New Jersey
1999 Monsanto and Pharmacia & Upjohn announce merger agreement
1999 Pharmacia & Upjohn acquires SUGEN, Inc.
1999 CELEBREX is launched
1999 Pharmacia & Upjohn establishes world headquarters in Somerset County, New Jersey
1997 Monsanto spins off chemical businesses as Solutia Inc.
1997 DETRUSITOL is launched
1996 XALATAN and CAMPTOSAR are launched
1995 Pharmacia & Upjohn created through merger of Pharmacia AB and The Upjohn Company
1993 Pharmacia AB created through the merger of Kabi Pharmacia and Carlo Erba
1990 Pharmacia and Kabi Vitrum merge to create Kabi Pharmacia
1987 GENOTROPIN is launched
1986 The Upjohn Company marks the 100th anniversary of its founding
1985 Monsanto acquires G.D. Searle & Company
1976 ROUNDUP herbicide is launched
1941 Searle establishes headquarters in Skokie, Illinois
1931 Kabi Vitrum established in Sweden
1911 Pharmacia established in Sweden
1908 G.D. Searle & Company is incorporated in Chicago
1901 Monsanto Chemical Works is founded by John Queeny in St. Louis, Missouri
1888 G.D. Searle & Company is founded by Gideon D. Searle in Omaha, Nebraska
1886 The Upjohn Company is founded by W.E. Upjohn in Kalamazoo, Michigan
1853 Carlo Erba company founded in Italy by pharmacist Carlo Erba